Entrada Therapeutics
TRDA
#9077
Rank
A$0.25 B
Marketcap
A$6.57
Share price
-6.25%
Change (1 day)
-58.02%
Change (1 year)

Earnings for Entrada Therapeutics (TRDA)

Earnings in 2026 (TTM): -A$0.27 Billion

According to Entrada Therapeutics's latest financial reports the company's current earnings are A$4.68 Million. In 2025 the company made an earning of -A$0.24 Billion a decrease over its 2024 earnings that were of A$71.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Entrada Therapeutics from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.27 Billion9.14%
2025 -A$0.24 Billion-435.87%
2024 A$71.02 M-1586.75%
2023 -A$4.78 Million-96.75%
2022 -A$0.15 Billion90.21%
2021 -A$77.25 Million